News

A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
Insmed has received FDA clearance for the first treatment for a chronic lung disease, opening the biotech up to what could be ...
An all-hands meeting at the CDC to discuss the attack on the agency on Friday was brief and chaotic, staffers say.
Issues are piling up on Kennedy's watch, from responding to the CDC shooting to infighting over an FDA official.
Pfizer said its antibody-drug conjugate Padcev extended survival when combined with the immunotherapy Keytruda in some ...
So is a 500,000-square-foot lab building up the street, as well as one in Boston near Fenway Park. A sprawling complex on ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
If we don’t act now, we’ll lose one of the most efficient, cost-effective access points in the U.S. health care system,” ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...
In at least six internal calls on Monday, CDC employees told leaders they worried that the agency wasn’t prepared for future ...
Even after Chris Sanford lost 130 pounds, he struggled with body dysmorphia. Every time he looked at the streamlined bodies ...